Why the study?
Does Angiotensin II induce cardiac metabolic inefficiency and insulin resistance via PDK4 in a mouse model of hypertrophy?
Does Angiotensin II induce cardiac metabolic inefficiency and insulin resistance via PDK4 in a mouse model of hypertrophy?
ANG II induces cardiac metabolic inefficiency and insulin resistance via increased PDK4 levels, highlighting a critical mechanistic pathway in heart failure.
No takes yet. Share an insight, caveat, or question.
PDK4 inhibition merits testing in diastolic dysfunction models; leaves open translation to human heart failure therapy.
Mori et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: